Discover
ITRM
Iterum Therapeutics PLC
0.03
30 x 0.00
1 x 0.04
bid
ask
+
0.00
0.00%
16 @ 04:00 PM
0.03 +0.00 (5.00%)
| Ytd | -91.04% | |
| 1y | -96.91% |
0.03
day range
0.05
0.81
52 week range
3.02
| Open | 0.04 | Prev Close | 0.03 | Low | 0.03 | High | 0.05 | Mkt Cap | 48.98M |
| Vol | 49.30M | Avg Vol | 2.88M | EPS | -1.76 | P/E | N/A | Forward P/E | -2.70 |
| Beta | 2.25 | Short Ratio | 0.46 | Inst. Own | 8.99% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-15 | 50-d Avg | 1.63 | 200-d Avg | 1.40 | 1yr Est | 7.50 |
| Income Statement | |||
| Total Revenue | 390.00K | ||
| Revenues (USD) | 390.00K | ||
| Cost of Revenue | 20.00K | ||
| Gross Profit | 370.00K | ||
| Operating Expenses | 8.10M | ||
| Research and Development Expense | 1.26M | ||
| Selling, General and Administrative Expense | 6.49M | ||
| Operating Income | -7.73M | ||
| Interest Expense | 441.00K | ||
| Income Tax Expense | 132.00K | ||
| Net Income | -8.98M | ||
| Net Income Common Stock | -8.98M | ||
| Net Income Common Stock (USD) | -8.98M | ||
| Consolidated Income | -8.98M | ||
| Earnings per Basic Share | -0.20 | ||
| Earnings per Basic Share (USD) | -0.20 | ||
| Earnings per Diluted Share | -0.20 | ||
| Earning Before Interest & Taxes (EBIT) | -8.41M | ||
| Earning Before Interest & Taxes (USD) | -8.41M | ||
| Weighted Average Shares | 45.80M | ||
| Weighted Average Shares Diluted | 45.80M | ||
| Balance Sheet | |||
| Cash and Equivalents | 11.03M | ||
| Cash and Equivalents (USD) | 11.03M | ||
| Trade and Non-Trade Receivables | 448.00K | ||
| Current Assets | 13.73M | ||
| Property, Plant & Equipment Net | 18.00K | ||
| Total Assets | 32.50M | ||
| Debt Current | 281.00K | ||
| Total Debt | 33.74M | ||
| Current Liabilities | 6.43M | ||
| Debt Non-Current | 33.45M | ||
| Total Liabilities | 39.88M | ||
| Accumulated Retained Earnings (Deficit) | -506.45M | ||
| Shareholders Equity | -7.38M | ||
| Shareholders Equity (USD) | -7.38M | ||
| Assets Non-Current | 18.78M | ||
| Total Debt (USD) | 33.74M | ||
| Goodwill and Intangible Assets | 18.71M | ||
| Inventory | 1.15M | ||
| Liabilities Non-Current | 33.45M | ||
| Trade and Non-Trade Payables | 577.00K | ||
| Tax Liabilities | 24.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 355.00K | ||
| Net Cash Flow from Financing | 5.43M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.03M | ||
| Capital Expenditure | -12.00K | ||
| Issuance (Purchase) of Equity Shares | 5.43M | ||
| Net Cash Flow from Investing | -12.00K | ||
| Net Cash Flow from Operations | -7.45M | ||
| Effect of Exchange Rate Changes on Cash | -2.00K | ||
| Share Based Compensation | 53.00K | ||